期刊文献+

^(99)Tc^m直接标记α_yβ_3受体拮抗剂环形RGD多肽 被引量:1

A direct radiolabeling of ^(99)Tc^m cyclic RGD peptide,an antagonist of α_vβ_3 receptor
下载PDF
导出
摘要 目的探讨^(99)Tc^m 直接标记α_vβ_3受体配体——含2个二硫键的精氨酸-甘氨酸-天冬氨酸(RGD)-九肽(RGD-4CK)的可行性和不同标记条件对标记率的影响。方法采用预锡化法^(99)Tc^m 直接标记 RGD-4CK,3 MM 色谱纸层析测定^(99)Tc^m-RGD-4CK 的 Rf 值,计算标记率与比活度。研究各种标记条件对^(99)Tc^m-RGD-4CK 标记率的影响。通过高效液相色谱仪(HPLC)分析,Sep-Pak C18柱层析,进行体外稳定性实验、半胱氨酸置换实验以及血清蛋白结合实验,评价^(99)Tc^m-RGD-4CK 的放射化学性质。结果 ^(99)Tc^m-RGD-4CK 在以丙酮和V(氨水):V(乙醇):V(水)=1:2:5为流动相中的 Rf 值分别为0与0.8~0.9,标记率为(97.8±0.4)%,基础标记条件下的比活度为(11.90±0.05)TBq/mmol。在以下条件下放化纯均>95%:(1)酒石酸亚锡为150~300 μg;(2)预锡化反应 pH 值为2.0~3.5,温度60℃,保温时间6 h 以上;(3)^(99)Tc^m O_4^-活度为37~185 MBq,体积在200μl内;(4)标记温度为95℃,标记时间30 min。^(99)Tc^m-RGD-4CK HPLC 的保留时间与其洗脱液的放射峰基本一致;^(99)Tc^m-RGD-4CK 室温放置6 h,放化纯仍>95%;Sep-Pak C18柱层析测定的^(99)Tc^m O_4^-峰仅比3 MM 纸层析高0.5%;标记物与300 mmol/L 半胱氨酸37%保温1 h,^(99)Tc^m O_4^-峰仅增加1.88%;^(99)Tc^m-RGD-4CK 与血清蛋白无明显结合。结论预锡化法^(99)Tc^m 直接标记 RGD-4CK 方法简便、标记率高,无需分离纯化即可直接应用,还可用于制备冻干品药盒。标记产物^(99)Tc^m-RGD-4CK 具有良好的放射化学性质。 Objective It has been repotted that Cys-Asp-Cys-Arg-Gly-Asp-Cys-Lys-Cys (RGD) peptides, as integfin αvβ3 receptor antagonists, might inhibit angiogenesis of tumor. The aim of the present study was to investigate the feasibility of direct labeling of ^99Tc^m to a cyclic nine peptide containing RGD sequence ( RGD-4CK), to observe the effects of different conditions on labeling efficiency, and to evaluate the radiochemical property of ^99Tc^m-RGD-4CK. Methods The peptide RGD-4CK contained the sequence of Cys-Asp-Cys-Arg-Gly-Asp-Cys-Lys-Cys. It was labeled directly by 99Tern with "pretinning" method. The Rf value of ^99Tc^m-RGD-4CK and ^99Tc^mO4 were determined in 3 MM paper chromatography. The labeling efficiency and specific activity were calculated. The influences of various conditions to the labeling rate were studied. High performance liquid chromatography (HPLC) analysis and Sep-Pak C18 chromatography were used to assess the property of radiolabeled ^99Tc^m-RGD-4CK. The stability in vitro, the cysteine replacement and the serum protein combination were also tested. Results The Rf values of ^99Tc^m-RGD-4CK were 0 and 0.8 ~ 0.9 respectively in mobile phase of acetone and V( NH4 OH ) : V(ethanol) : V(water) = 1 : 2: 5. The radiochemical yield was (97.8 ± 0.4)% and the specific activity (11.90 ± 0.05 ) TBq/mmol in the basic condition of labeling. The labeling efficiency remained over 95% under the condition of 150± 300μg stannous tartrate, pH value 2.0 ± 3.5, temperature 60℃ and incubation time over 6 h in the process of pretinning reaction, the activity of ^99Tc^mO4- was 37 - 185 MBq within volume of 200 μl. With the labeling temperature of 95℃ in 30 min, the retention of ^99Tc^m-RGD-4CK was in accordance with the major peak of timeactivity curve from the analytical HPLC. The radiochemical purity of 99Tc^m -RGD-4CK remained above 95% after 6 h at room temperature. The amount of ^99Tc^m O4^- increased only by 0.5% as measured with Sep-Pak C18 chromatography. The free ^99Tc^mO4^- from the labeled product increased by 1.88% after incubation with 300 mmol/L cysteine for 1 h at 37℃. There was no obvious binding of ^99Tc^m-RGD-4CK to serum protein. Conclusions This study indicated that direct " pretinning" techniques was practical in preparing ^99Tc^m- RGD-4CK with acceptable labeling efficiency and radiochemical characteristics, and might be potentially useful in future preparation of ^99Tc^m-RGD-4CK kit.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2007年第2期103-106,共4页 Chinese Journal of Nuclear Medicine
基金 国家自然科学基金(30370425)
关键词 肽类 同位素标记 Peptides Technetium Isotope labeling
  • 相关文献

参考文献11

  • 1Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest, 1999, 103: 1227-1230.
  • 2Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology ( N Y), 1995, 13: 265- 270.
  • 3刘广元,李前伟,黄定德,刘开元,谢来平,陈杰,罗朝学.^(99)Tc^m-RGD-4CK在动物体内的分布及显像[J].中华核医学杂志,2007,27(1):34-37. 被引量:5
  • 4Su ZF, He J, Rusckowski M, et al. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as coligands. Nucl Med Biol, 2003, 30: 141-149.
  • 5Haubner R, Bruchertseifer F, Bock M, et al. Synthesis and biological evaluation of a ^99Tc^m-labelled cyclic RGD peptide for imaging the αvβ3 expression. Nuklearmedizin, 2004, 43: 26-32.
  • 6van-Hagen PM, Breeman WA, Bernard HF, et al. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. Int J Cancer, 2000, 90: 186-198.
  • 7Wu Y, Zhang X, Xiong Z, et al. microPET imaging of glioma integrin { alpha } v{ beta } 3 expression using (64) Cu-labeled tetrameric RGD peptide. J Nucl Med, 2005, 46: 1707-1718.
  • 8Beer A J, Haubner R, Goebel M, et al. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer ^18F-galacto-RGD in cancer patients. J Nucl Med, 2005, 46 : 1333-1341.
  • 9Chen X, Park R, Khankaldyyan V, et al. Longitudinal microPET imaging of brain tumor growth with F-18-1abeled RGD peptide. Mol Imaging Biol, 2006, 8:9-15.
  • 10Thakur ML, Kolan H, Li J, et al. Radiolabeled somatostatin analogs in prostate cancer. Nucl Med Biol, 1997, 24: 105-113.

二级参考文献11

  • 1Max R, Gerritsen RR, Nooijen PT, et al. Immunohistochemical analysis of intgerin alpha v beta 3 expression on tumor-associated vessels of human carcinomas. Int J Cancer, 1997, 71 : 320-324.
  • 2Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis : insights into potential mechanisms of action and clinical development. J Clin Invest, 1999, 103: 1227-1230.
  • 3Kerr JS, Slee AM, Mousa SA. Small molecule alpha (v) integrin antagonists: novel anticancer agents. Expert Opin Investig Drugs, 2000, 9 : 1271-1279.
  • 4Dechantsreiter MA, Planker E, Matha B, et al. N-Methylated cyclic RGD peptides as highly active and selective alpha ( V ) beta (3) integrin antagonists. J Med Chem, 1999, 42: 3033-3040.
  • 5Pervez S, Mushtaq A, Arif M. ^99Tc^m direct radiolabeling of lanreotide: a somatostatin analog. Appl Radiat Isot, 2001, 55: 647- 651.
  • 6Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnol NY, 1995, 13 : 265-270.
  • 7Su ZF, He J, Rusckowski M, et al. In vitro cell studies of ^99Tc^m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands. Nucl Med Biol, 2003, 30: 141-149.
  • 8Haubner R, Bruchertseifer F, Bock M, et al. Synthesis and biological evaluation of a ^99Tc^m labelled cyclic RGD peptide for imaging the αvβ3 expression. Nuklearmedizin, 2004, 43: 26-32.
  • 9Wu Y, Zhang X, Xiong Z, et al. microPET imaging of glioma integrin { alpha } α { beta } β expression using ( 64 ) Cu labeled tetrameric RGD peptide. J Nucl Med, 2005, 46: 1707-1718.
  • 10Folkman J. Addressing tumor blood vessels. Nat Biotechnol, 1997, 15: 510.

共引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部